Interfering with disease: a progress report on siRNA-based therapeutics

被引：971

作者：

de Fougerolles, Antonin

Vornlocher, Hans-Peter

Maraganore, John

Lieberman, Judy

机构：

[1] Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA

[2] Alnylam Europe AG, D-95326 Kulmbach, Germany

[3] CBR Inst Biomed Res, Boston, MA 02115 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2007年 / 6卷 / 06期

关键词：

D O I：

10.1038/nrd2310

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

RNA interference (RNAi) quietly crept into biological research in the 1990s when unexpected gene-silencing phenomena in plants and flatworms first perplexed scientists. Following the demonstration of RNAi in mammalian cells in 2001, it was quickly realized that this highly specific mechanism of sequence-specific gene silencing might be harnessed to develop a new class of drugs that interfere with disease-causing or disease-promoting genes. Here we discuss the considerations that go into developing RNAi-based therapeutics starting from in vitro lead design and identification, to in vivo pre-clinical drug delivery and testing. We conclude by reviewing the latest clinical experience with RNAi therapeutics.

引用

收藏

页码：443 / 453

页数：11

相关论文

共 104 条

[51] GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery [J].

Li, WJ ;

Nicol, F ;

Szoka, FC .

ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (07) :967-985

[52] siRNA-mediated off-target gene silencing triggered by a 7 nt complementation [J].

Lin, XY ;

Ruan, X ;

Anderson, MG ;

McDowell, JA ;

Kroeger, PE ;

Fesik, SW ;

Shen, Y .

NUCLEIC ACIDS RESEARCH, 2005, 33 (14) :4527-4535

[53] MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies [J].

Liu, JD ;

Valencia-Sanchez, MA ;

Hannon, GJ ;

Parker, R .

NATURE CELL BIOLOGY, 2005, 7 (07) :719-U118

[54] In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury [J].

Lomas-Neira, JL ;

Chung, CS ;

Wesche, DE ;

Perl, M ;

Ayala, A .

JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 77 (06) :846-853

[55] Effective targeting of liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid sequence [J].

Longmuir, KJ ;

Robertson, RT ;

Haynes, SM ;

Baratta, JL ;

Waring, AJ .

PHARMACEUTICAL RESEARCH, 2006, 23 (04) :759-769

[56] An efficient intrathecal delivery of small interfering RNA to the spinal cord and peripheral neurons [J].

Luo, Miaw-Chyi ;

Zhang, Dong-Qin ;

Ma, Shou-Wu ;

Huang, Yuan-Yuan ;

Shuster, Sam J. ;

Porreca, Frank ;

Lai, Josephine .

MOLECULAR PAIN, 2005, 1

[57] Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake [J].

Makimura, Hideo ;

Mizuno, Tooru M. ;

Mastaitis, Jason W. ;

Agami, Reuven ;

Mobbs, Charles V. .

BMC NEUROSCIENCE, 2002, 3 (1)

[58] Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes [J].

Matranga, C ;

Tomari, Y ;

Shin, C ;

Bartel, DP ;

Zamore, PD .

CELL, 2005, 123 (04) :607-620

[59] RETRACTED: Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation (Retracted Article. See vol 181, pg 6671, 2008) [J].

Matsuyama, W ;

Watanabe, M ;

Shirahama, Y ;

Hirano, R ;

Mitsuyama, H ;

Higashimoto, I ;

Osame, M ;

Arimura, K .

JOURNAL OF IMMUNOLOGY, 2006, 176 (03) :1928-1936

[60] Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras [J].

McNamara, James O. ;

Andrechek, Eran R. ;

Wang, Yong ;

D Viles, Kristi ;

Rempel, Rachel E. ;

Gilboa, Eli ;

Sullenger, Bruce A. ;

Giangrande, Paloma H. .

NATURE BIOTECHNOLOGY, 2006, 24 (08) :1005-1015

← 1 2 3 4 5 6 7 8 9 10 →